ROS production in PMN-MDSCs at tumor sites decreases, whereas ARG1 and other suppressive factors, such as IDO and prostaglandin E2 (PGE2), which are produced by PMN-MDSCs, drive non-specific T cell suppression. Here, IDO1 is linked to neoplasm.